Psychiatry & Neurology, Clinical Neurophysiology · Statesboro, GA
NPI
1700947231
Since 2006
Specialty
Psychiatry & Neurology, Clinical Neurophysiology
Code 2084N0600X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1497 Fair Rd, Suite 201
Statesboro, GA, 30458
Phone (912) 486-1140
Groups this clinician bills Medicare through
Medicare paid, 2024
$123K
1,496 services
Medicare patients, 2024
349
Average age 72
Drug cost, 2024
$2.3M
3,430 prescriptions
Company payments, 2025
$2,014
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kashyap Patel was code 99214 (office e&m - established), 309 times for 144 patients. In total Kashyap Patel billed 1,496 services in 18 codes, and Medicare paid $123K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 309 | 144 | $88.76 | $27K |
| 99213 Office E&M - Established | Office | 287 | 175 | $64.05 | $18K |
| 95886 Electrical Nerve Conductivity | Office | 192 | 76 | $73.93 | $14K |
| 99203 Office E&M - New | Office | 110 | 110 | $73.02 | $8,033 |
| 95913 Electrical Nerve Conductivity | Office | 95 | 74 | $214.16 | $20K |
| 99406 Behavioral Health Services | Office | 79 | 40 | $14.09 | $1,113 |
| 99204 Office E&M - New | Office | 66 | 66 | $110.99 | $7,325 |
| 93922 Duplex Scan - Extremity Arteries | Office | 57 | 57 | $61.35 | $3,497 |
| 95921 Electrical Nerve Conductivity | Office | 56 | 56 | $67.03 | $3,753 |
| 95923 Electrical Nerve Conductivity | Office | 56 | 56 | $76.80 | $4,301 |
| 92537 Test - Miscellaneous | Office | 53 | 53 | $31.02 | $1,644 |
| 92548 Test - Miscellaneous | Office | 53 | 53 | $36.67 | $1,944 |
| 92540 Vision, Hearing, and Speech Services | Office | 53 | 53 | $77.24 | $4,094 |
| 95819 Neurologic | Office | 16 | 16 | $339.04 | $5,425 |
By year: 2022 $205K for 2,552 services; 2023 $189K for 2,416 services; 2024 $123K for 1,496 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kashyap Patel prescribed most often to Medicare patients was Donepezil Hcl, with 294 prescriptions and refills. In total Kashyap Patel wrote 3,430 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 294 | 433 | 73 | $1,707 |
| Topiramate Generic | 284 | 352 | 53 | $2,032 |
| Levetiracetam Generic | 236 | 359 | 45 | $4,456 |
| Lacosamide Generic | 227 | 255 | 40 | $12K |
| Nurtec Odt Rimegepant Sulfate | 200 | 200 | 28 | $383K |
| Ropinirole Hcl Generic | 167 | 217 | 33 | $2,658 |
| Lamotrigine Generic | 166 | 194 | 22 | $2,241 |
| Primidone Generic | 156 | 229 | 45 | $3,152 |
| Gabapentin Generic | 150 | 194 | 27 | $2,395 |
| Ajovy Autoinjector Fremanezumab-Vfrm | 148 | 164 | 20 | $118K |
| Emgality Pen Galcanezumab-Gnlm | 124 | 134 | 20 | $90K |
| Ubrelvy Ubrogepant | 104 | 113 | 15 | $180K |
| Ztlido Lidocaine | 85 | 85 | 12 | $33K |
| Amitriptyline Hcl Generic | 80 | 132 | 17 | $875 |
| Botox Onabotulinumtoxina | 74 | 215 | 24 | $99K |
Brand drugs: 1,153 claims; generic drugs: 2,264 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kashyap Patel $2,014 ($2,014 in general payments such as food, travel and fees) from 23 companies. The largest payer was Novartis Pharmaceuticals Corporation with $313.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 13 | $313 |
| Catalyst Pharmaceuticals, Inc. CPRX | 9 | $245 |
| Neurelis, Inc. | 11 | $240 |
| Teva Pharmaceuticals USA, Inc. TEVA | 10 | $219 |
| UCB, Inc. UCB.BR | 6 | $138 |
| Pfizer Inc. PFE | 7 | $137 |
| Janssen Biotech, Inc. JNJ | 4 | $101 |
| Jazz Pharmaceuticals Inc. JAZZ | 4 | $89.19 |
| Lundbeck LLC | 3 | $63.68 |
| Argenx US, Inc. ARGX | 3 | $62.49 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.